Kazia Therapeutics (KZIA) Debt Ratio (2011 - 2025)

Kazia Therapeutics (KZIA) reported Debt Ratio of 0.2 for Q4 2025, up 77.01% on a YoY basis from 0.11 in Q4 2024, and down 61.64% quarter-over-quarter from 0.52 in Q2 2025.

Kazia Therapeutics (KZIA) Debt Ratio (2011 - 2025) Analysis & Trends

Kazia Therapeutics has reported Debt Ratio for 6 years, with the latest figure at 0.2 in Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 77.01% year-over-year to 0.2; the trailing twelve-month figure through Dec 2025 stood at 0.2 (up 77.01% YoY), and the FY2025 full-year result was 0.52, up 73.23% from the prior year.
  • Debt Ratio for Q4 2025 stood at 0.2, down from 0.52 in the prior quarter.
  • The five-year high for Debt Ratio was 0.52 in Q2 2025, with the low at 0.05 in Q2 2022.
  • Historically, Debt Ratio has averaged 0.25 across 4 years, with a median of 0.3 in 2024.
  • Annual changes were most pronounced in 2023 — Debt Ratio surged 666.25% — and 2024, when it plunged 68.06%.
  • Kazia Therapeutics' Debt Ratio stood at 0.05 in 2022, then jumped by 752.28% to 0.35 in 2023, then sank by 68.06% to 0.11 in 2024, then jumped by 77.01% to 0.2 in 2025.
  • The last three Debt Ratio figures came in at 0.2 (Q4 2025), 0.52 (Q2 2025), and 0.11 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Kazia Therapeutics 1.70 Bn 1.70 Bn - 0.20

Historic Data

Download Data
DateValue
Dec 31, 2025 0.20
Jun 30, 2025 0.52
Dec 31, 2024 0.11
Jun 30, 2024 0.30
Dec 31, 2023 0.35
Jun 30, 2023 0.31
Jun 30, 2022 -0.05
Jun 30, 2018 0.00
Jun 30, 2011 0.08